Oxcarbazepine Tablet, Film Coated
Product Images NDC 70518-4664

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-4664). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description of OXCaI'baZEPIHE Tablet, with a strength of 600 mg manufactured by Breckenridge in Boca Raton, FL. The typical dosage information is provided on the insert. Keep the medication away from children and store at 20-25°C (68-77°F). The package contains 30 Tablets, with storage excursions allowed to 15-30°C (59-86°F). The NDC number for this product is 70618-4664-00. Additional information includes the LOT number, expiration date, and being repackaged by RemedyRepack. For more details, contact Remedy Inc. in Indiana, PA, at 724.465.8762.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

FDA Label Image

Figure 1 (Oxcarbazepine 02)

This text provides information about the exit rate data comparison between two treatments - Oxcarbazepine and Placebo. The log-rank test was conducted with a p-value of 0.0001. Days since the start of the trial are also presented, focusing on Day 2 and Day 11. The study seems to be evaluating the time on trial and potentially the effectiveness of the treatments.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

This description provides information on the seizure rate, log-rank test result with a p-value of 0.046, and a timeline showing days from the 1st dose to the 1st seizure for the treatment groups Oxcarbazepine and Placebo. The data includes values for different time points.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

This information appears to be a data table showing exit rates and time to exit (in days) for two treatment groups, high and low. The exit rates are recorded at intervals from 10 to 130 days. This data could be used for analyzing the effectiveness of different treatments in relation to the time it takes for subjects to exit a study or experiment.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

This appears to be a chart showing the exit rate over time for two treatment groups, labeled as HIGH and LOW. The data is plotted at different time intervals (10, 20, ..., 130 days). The "Time to exit" is measured in days. The chart may be used to analyze the effectiveness of the treatments in terms of the exit rate from a certain scenario or environment.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.